10 results
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
to our reputation and significant negative media attention.
Any such outcomes could materially adversely affect our business, financial condition … the regulatory approval of such product candidate, could cause us to incur fines or penalties or could harm our reputation and that of our product
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
;
the inability to commercialize any product candidate that we may develop; and
injury to our reputation and significant negative media attention.
Any … to incur fines or penalties or could harm our reputation and that of our product candidates.
We may make changes to our manufacturing process
S-1/A
EX-10.1
COYA
Coya Therapeutics Inc
5 Dec 22
IPO registration (amended)
8:16am
Service for Cause, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Affiliates.
9
S-1/A
cpwgnw0cef zin18ve5
5 Dec 22
IPO registration (amended)
8:16am
S-1
qp3mg93ip7
18 Nov 22
IPO registration
5:06pm
DRS/A
abcrq
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
w142oiwhp80
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
t2ia 1c7488biq
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next